semlerresearch

Part of US based
Semler Group of Companies,
in business since 1946

Sitemap

YOU ARE HERE: Home News & Events Latest News
Latest News
SRC successfully completes 5th WHO inspection!

The inspection focused on the bio-equivalence studies conducted at Semler Research Center. The inspection covered all the sections of the GCP and GLP, including the WHO guidance for organizations performing in-vivo bioequivalence studies. Inspectors visited the facility to review the study documents generated at clinical facility & Bio analytical facility at Bangalore for 10 mandays from 27 Jan 2015 to 31 Jan 2015. The inspection was completed successfully.

 
SRC wins the Bio Excellence award for the "Emerging Company of the year 2015" under the BioServices category!

Bio-excellence awards are presented to the Biotech leaders for their outstanding achievements in the Biotech sector. An independent jury of industry experts constituted by Association of Biotechnology Led Enterprises (ABLE ), selected “Semler Research Centre Pvt Ltd” as the “Emerging Company of the Year 2015” under the BioServices category amongst various nominations from different categories.

The formal award would be presented during Bangalore INDIA BIO 2015 event scheduled from 9th Feb 2015 to 11th Feb 2015 and the event is being organised by Dept of IT, BT & ST , Government of Karnataka.

 
SRC successfully completes 8th USFDA Inspection

The inspection focused on 2 bio-equivalence studies conducted for the product. USFDA inspectors visited the facility to review documents related to the studies generated at the Clinical facility and Bioanalytical facility, Bangalore. Both the studies were approved by the regulatory.

 
Semler Research Center inspected and approved by EMA

The inspection focused on the bio-equivalence study conducted for the product. EMA inspectors visited the facility to review study documents generated at Clinical facility and Bioanalytical facility, Bangalore. The study was approved by the regulatory.

 
Semler Research Center inspected and approved by ANVISA

The inspection focused on the bio-equivalence study conducted for the product. ANVISA inspectors visited the facility to review study documents generated at the Clinical facility, Salem and the Bioanalytical facility, Bangalore. The study was approved by the regulatory.

 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  Next 
  •  End 
  • »


Page 1 of 4

Quick Contact

INDIA Tel: +91 80 4262 7200

US Tel: +1 818 760 1000

info@semlerresearch.com